Debevoise & Plimpton LLP houses a team known for its strength in acquisitions and class actions across the pharma and healthcare spaces. Andrew Bab is noted for his vast experience in private equity-focused healthcare and life sciences work, and M&A. Mark Goodman is a key contact for all matters relating to commercial litigation and white-collar crime within the healthcare space, areas in which Maura Monaghan is also an expert. Kevin Rinker has deep knowledge of private equity buyouts, as does Jennifer Chu, and Washington DC-based Paul Rubin is a key figure within the team, known for his experience in FDA and FTC compliance work, and the regulatory aspects of M&A.
Legal 500 redaktioneller Kommentar
- Profil
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘High level of expertise with wide range of complementary skills.’
‘Extraordinary team who work incredibly well together and maximize their different skills and areas of expertise.’
‘Very professional, capable and experienced in Healthcare M&A.’
Kernmandanten
- agilon
- Former CEO of Sandoz
- Carlyle
- Former directors and shareholders of Purdue Pharma, Inc.
- Clayton, Dubilier & Rice, LLC
- Deutsche Bank
- EmblemHealth
- Group Health Incorporated, Inc.
- Gedeon Richter
- Gentiva
Highlight-Mandate
Advised Clayton, Dubilier & Rice on its acquisition, together with TowerBrook Capital Partners, of R1 RCM Inc. at an enterprise value of $8.9bn.
Representing certain former directors and shareholders of Purdue Pharma, Inc., in defending litigation regarding prescription opioids in numerous for a across the country, including a federal multi-district litigation, actions brought by states attorneys general and a high-profile case before the US Supreme Court, and in efforts to negotiate a global settlement in bankruptcy court.
Obtained a highly favorable settlement for EmblemHealth and its subsidiary Group Health Incorporated in a long-running putative class action lawsuit.
Anwält*innen
Praxisleitung
Andrew Bab; Jennifer Chu; Mark Goodman; Maura Monaghan; Kevin Rinker; Paul Rubin